<div dir="ltr"><div dir="ltr"><span id="gmail-docs-internal-guid-6a485608-7fff-059a-1f4d-f3b6397fa751"><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:11pt;font-family:Arial,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">(Apologies for cross-posting)</span></p><br><p dir="ltr" style="line-height:1.44;text-align:center;margin-top:10pt;margin-bottom:10pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">CFP: ToxHabits Shared Task </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">(BioCreative IX will be colocated with </span><a href="https://2025.ijcai.org/" style="text-decoration-line:none"><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;text-decoration-line:underline;vertical-align:baseline">IJCAI 2025</span></a><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"> in Montreal, CA) </span></p><p dir="ltr" style="line-height:1.44;text-align:center;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Named entity recognition of toxic habits including substance abuse, smoking & alcohol consumption in clinical texts</span></p><p dir="ltr" style="line-height:1.44;text-align:center;margin-top:0pt;margin-bottom:0pt;padding:0pt 0pt 10pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(17,85,204);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;text-decoration-line:underline;vertical-align:baseline"><a href="https://temu.bsc.es/toxhabits/">https://temu.bsc.es/toxhabits/</a></span><span style="background-color:transparent;color:rgb(0,0,0);font-family:Arial,sans-serif;font-size:11pt"> </span></p><p dir="ltr" style="line-height:1.44;text-align:justify;margin-top:0pt;margin-bottom:0pt;padding:10pt 0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">The ToxHabits track focuses on the automatic detection of toxic habit entity mentions in clinical case reports written in Spanish. We also plan to release a multilingual version of the dataset, including versions in English and other languages.</span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Key information:</span></p><ul style="margin-top:0px;margin-bottom:0px"><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Arial,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre;margin-left:11pt"><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Web</span><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">: <a href="https://temu.bsc.es/toxhabits/">https://temu.bsc.es/toxhabits/</a></span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Arial,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre;margin-left:11pt"><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Data</span><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">:</span><a href="https://doi.org/10.5281/zenodo.6408476" style="text-decoration-line:none"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"> </span></a><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(17,85,204);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;text-decoration-line:underline;vertical-align:baseline"><a href="https://zenodo.org/records/15304758">https://zenodo.org/records/15304758</a></span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre;margin-left:11pt"><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">BioCreative web</span><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">: <a href="https://www.ncbi.nlm.nih.gov/research/bionlp/biocreative">https://www.ncbi.nlm.nih.gov/research/bionlp/biocreative</a></span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre;margin-left:11pt"><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Registration form (</span><span style="font-size:10pt;color:rgb(32,33,36);font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Track 3- ToxHabits</span><span style="font-size:10pt;background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">)</span><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">:</span><a href="https://temu.bsc.es/distemist/registration/" style="text-decoration-line:none"><span style="font-size:10pt;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"> </span></a><span style="font-size:10pt;color:rgb(17,85,204);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;text-decoration-line:underline;vertical-align:baseline"><a href="https://docs.google.com/forms/d/e/1FAIpQLSeHe9rLVGHGNtK0ExUFlNyGBJJ_VKPScx-N5ODBJbk3v5DoMQ/viewform">https://docs.google.com/forms/d/e/1FAIpQLSeHe9rLVGHGNtK0ExUFlNyGBJJ_VKPScx-N5ODBJbk3v5DoMQ/viewform</a></span></p></li></ul><p dir="ltr" style="line-height:1.44;text-align:justify;margin-top:10pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(17,85,204);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;text-decoration-line:underline;vertical-align:baseline"><br></span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Motivation</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><br></span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Systems capable of detecting and characterizing toxic habits—including not only smoking and alcohol consumption but also various forms of drug or substance abuse—from medical texts are crucial for nearly all healthcare data mining, medical AI, and predictive clinical applications. There is a pressing need to automatically extract toxic habit information, especially considering that, according to recent drug abuse statistics, in some countries nearly half of individuals aged 12 and older have used illicit drugs at least once. In the United States alone, drug overdose deaths since 2000 are approaching one million. These figures highlight a clear global burden and the urgent need to improve the systematic extraction and characterization of substance abuse information.</span></p><p dir="ltr" style="line-height:1.44;text-align:justify;margin-top:12pt;margin-bottom:12pt;padding:0pt 0pt 10pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">To address these challenges, we have proposed the ToxHabits track as part of the upcoming BioCreative IX initiative, which will be held in conjunction with the prestigious IJCAI 2025 international conference.</span></p><p dir="ltr" style="line-height:1.44;text-align:justify;margin-top:0pt;margin-bottom:10pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Automatic detection of toxic habits are key for a range of clinical use cases and applications:</span></p><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">1. </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Risk Assessment for Chronic Diseases</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">: Toxic habits are major risk factors for cardiovascular disease, chronic obstructive pulmonary disease (COPD), liver cirrhosis, and cancer. Knowing these habits aids in risk stratification and preventive care planning.</span></p><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">2. </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Anesthesia and Surgical Planning</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">: Substance use can affect anesthetic response, bleeding risk, wound healing, and postoperative complications. For instance, alcohol and smoking increase the risk of surgical site infections.</span></p><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">3. </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Mental Health Diagnosis and Management</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">: Substance abuse is closely linked with depression, anxiety, psychosis, and suicidal behavior. Accurate assessment is critical for correct psychiatric diagnosis and effective treatment.</span></p><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">4. </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Medication Metabolism and Drug Interactions</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">: Smoking (e.g., induces CYP1A2) and alcohol can alter drug metabolism. Drug abuse may interact with prescribed medications, leading to reduced efficacy or increased toxicity.</span></p><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">5. </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Prenatal and Maternal Care</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">: In pregnant patients, toxic habits pose risks for fetal alcohol syndrome, low birth weight, preterm birth, and developmental disorders. Early detection is key to harm reduction.</span></p><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">6. </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Infectious Disease Screening and Prevention</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">: Drug abuse, especially via injection, increases the risk of HIV, hepatitis B/C, and other transmissible infections. Alcohol abuse may contribute to high-risk behaviors increasing disease transmission.</span></p><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">7. </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Liver Function and Hepatology</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">: Chronic alcohol use is a major cause of fatty liver, hepatitis, and cirrhosis. Identifying alcohol use is crucial when evaluating liver enzyme abnormalities or planning hepatotoxic treatments.</span></p><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">8. </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Oncology</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">: Risk and Treatment Planning:Toxic habits are associated with cancers of the lung, liver, pancreas, oral cavity, and others. Continuing such habits during cancer treatment can affect prognosis and response.</span></p><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">9. </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Pain Management and Opioid Prescribing</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">: In patients with a history of substance abuse, opioid prescribing requires careful risk-benefit analysis and often alternative pain control strategies.</span></p><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">10. </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Emergency and Acute Care Triage</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">: In cases of trauma, overdose, or altered mental status, knowledge of toxic habits can guide differential diagnosis, antidote use, and monitoring strategies.</span></p><br><p dir="ltr" style="line-height:1.38;margin-top:12pt;margin-bottom:12pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Inspired by previous initiatives (e.g., n2c2, CLEF, or TREC) and shared tasks (e.g., Symptemist, PharmaCoNER, or DisTEMIST), we are launching the </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">ToxHabits</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"> shared task as part of the </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">BioCreative 2025</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"> evaluation initiative, featuring the following three sub-tracks:</span></p><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">ToxNER (Subtask 1): Substance Mention Detection</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><br></span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Participants are required to return the starting and ending character positions (spans) of each substance mention, along with its substance type (i.e., </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Tobacco</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">, </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Alcohol</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">, </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Drug</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">, or </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Cannabis</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">).</span></p><br><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">ToxUse (Subtask 2): Substance Use/Consumption Characteristics Detection</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><br></span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Participants must return the starting and ending character positions (spans) of substance use characteristics, along with the corresponding label (i.e., </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Amount</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">, </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Type</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">, </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Frequency</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">, </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Duration</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">, </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Method</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">, </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">History</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">).</span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><br></span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Tentative schedule</span></p><ul style="margin-top:0px;margin-bottom:0px"><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">ToxHabits registration: May 26th</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">ToxHabits Train set release: April 30th</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Annotation Guidelines release: TBA</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">ToxHabits Test set release:</span><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><span class="gmail-Apple-tab-span" style="text-wrap: nowrap;">       </span></span><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">May 26th</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">ToxHabits Test Prediction submission: June 1st (Anywhere on Earth)</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">ToxHabits results release:</span><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><span class="gmail-Apple-tab-span" style="text-wrap: nowrap;">     </span></span><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">June 5th</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">IJCAI’25 Workshop Team Invitation:</span><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><span class="gmail-Apple-tab-span" style="text-wrap: nowrap;">     </span></span><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">June 6th</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">BioCreative IX proceedings paper submission: June 16th</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">BioCreative IX proceedings paper reviews: July 1st</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">IJCAI 2025 August 16-22th (Montreal, Canada)</span></p></li></ul><br><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">BioCreative proceedings and IJCAI workshop</span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Teams participating in ToxHabits will be invited to contribute a system description paper to the </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">BioCreative 2025 Working Notes</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"> proceedings and to give a flash presentation of their approach during the BioCreative 2025 session. BioCreative IX will be co-located with </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">IJCAI 2025</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"> in Montreal, Canada. The meeting will take place from </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">August 16 to 22, 2025</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">.</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><br></span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"> For more information, see:</span><a href="https://2025.ijcai.org/" style="text-decoration-line:none"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"> </span><span style="font-size:10pt;font-family:Calibri,sans-serif;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;text-decoration-line:underline;vertical-align:baseline">https://2025.ijcai.org/</span></a></p><br><br><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Workshop Proceedings and Special Issue</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">:</span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">The </span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-style:italic;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">BioCreative IX Proceedings</span><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"> will include short systems description papers from participating teams and will be available by published online by the time of the workshop. In addition, we are pleased to announce that, following the tradition of previous BioCreative initiatives, top-performing teams will be invited to submit a longer technical journal paper for publication in a special issue. Invitations to submit will be sent after the workshop.</span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline"><br><br></span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">All BioCreative IX tracks</span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Track 1: MedHopQA</span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Track 2: Sentence Segmentation of Real-Life Clinical Notes</span></p><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">*Track 3: ToxHabits</span></p><br><p dir="ltr" style="line-height:1.44;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">See: <a href="https://www.ncbi.nlm.nih.gov/research/bionlp/biocreative9">https://www.ncbi.nlm.nih.gov/research/bionlp/biocreative9</a></span></p><br><br><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Organizers</span></p><ul style="margin-top:0px;margin-bottom:0px"><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Salvador Lima-López, Barcelona Supercomputing Center (BSC), Spain.</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Wesam Al-Nabki, Barcelona Supercomputing Center (BSC), Spain.</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Gabriel Vayá-Abad, Barcelona Supercomputing Center (BSC), Spain.</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Eulàlia Farré-Maduell, Barcelona Supercomputing Center (BSC), Spain.</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Jan Rodríguez Miret, Barcelona Supercomputing Center (BSC), Spain.</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Martin Krallinger, Barcelona Supercomputing Center (BSC), Spain.</span></p></li></ul><br><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt"><span style="font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-weight:700;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Scientific Committee</span></p><ul style="margin-top:0px;margin-bottom:0px"><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Dina Demner-Fushman, US National Institute of Health / National Library of Medicine</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Ozlem Uzuner, George Mason University</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Asma Ben Abacha, Microsoft Health AI</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Anastasios Nentidis, National Center for Scientific Research Demokritos, Greece</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Anastasia Krithara, National Center for Scientific Research Demokritos, Greece</span></p></li><li dir="ltr" style="list-style-type:disc;font-size:10pt;font-family:Calibri,sans-serif;color:rgb(0,0,0);background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline;white-space:pre"><p dir="ltr" style="line-height:1.38;margin-top:0pt;margin-bottom:0pt" role="presentation"><span style="font-size:10pt;background-color:transparent;font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;vertical-align:baseline">Lourdes Araujo, Universidad Nacional de Educación a Distancia (UNED)</span></p></li></ul><br></span></div></div>